Your browser version may not work well with NCBI's Web applications. More information here...
1: Ann Allergy Asthma Immunol. 2008 Jun;100(6):624-5.
Related Articles, Links
Click here to read
Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema.

Dreyfus DH.

Publication Types:
PMID: 18592835 [PubMed - indexed for MEDLINE]